News

JPMorgan's investment banking fees came in higher than their earlier guidance, growing by 7% to $2.5 billion. Troy Rohrbaugh, ...
Fresh data Tuesday from the consumer-price index showed ”some early signs” of the impact from tariffs, but inflation on the whole remained “muted,” according to Goldman Sachs Asset Management’s Kay ...
Eli Lilly and Company (NYSE: LLY) is one of Goldman Sachs’ top healthcare stock picks. On July 9, the company confirmed the ...
AstraZeneca PLC (NASDAQ:AZN) is one of Goldman Sachs’ top healthcare stock picks. On July 4, the company secured regulatory ...
Hadley, whose time at Goldman included working with newly appointed CEO Larry Restieri, will lead the firm's efforts at ...
Ben Gammell and Erik Zhou are building a CFO-CAO model grounded in trust, technical rigor and strategic clarity.
President Donald Trump and Sen. Dave McCormick of Pennsylvania will jointly announce roughly $70 billion of energy ...
As the August 1 deadline for President Trump's new tariffs approaches, global markets brace for potential economic fallout. Analysts speculate whether this will be another bluff or if the tariffs will ...
JPMorgan, Wells Fargo and BlackRock backed away from record highs after reporting second-quarter earnings early Tuesday. Citi topped estimates in the morning, as the big banks roll out the Q2 earnings ...
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of Goldman Sachs’ top healthcare stock picks. On July 1, the European Commission approved the company’s new cystic fibrosis treatment, ALYFTREK ...